High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody

Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy

(2015) Vidya Limaye et al.   MUSCLE & NERVE

Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing Myopathies

(2014) Yves Allenbach et al.   MEDICINE

Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies

(2014) Laurent Drouot et al.   ARTHRITIS RESEARCH & THERAPY

Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ

(2013) David F. Fiorentino et al.   ARTHRITIS AND RHEUMATISM

Acquired necrotizing myopathies

(2013) Yves Allenbach et al.   CURRENT OPINION IN NEUROLOGY

Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer

(2013) C. G. Joseph et al.   SCIENCE

Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: A systematic review and meta-analysis

(2011) Ernesto Trallero-Araguás et al.   ARTHRITIS AND RHEUMATISM

Malignancy in Myositis

(2011) Zaki Abou Zahr et al.   Current Rheumatology Reports

Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy

(2010) Andrew L. Mammen et al.   ARTHRITIS AND RHEUMATISM

Malignancy Is Associated with Dermatomyositis But Not Polymyositis in Northern New England, USA

(2009) B. B. ANTIOCHOS et al.   JOURNAL OF RHEUMATOLOGY